ATE190836T1 - Arzneimittelzusammensetzung mit kontrollierter wirkstoffabgabe - Google Patents

Arzneimittelzusammensetzung mit kontrollierter wirkstoffabgabe

Info

Publication number
ATE190836T1
ATE190836T1 AT94120709T AT94120709T ATE190836T1 AT E190836 T1 ATE190836 T1 AT E190836T1 AT 94120709 T AT94120709 T AT 94120709T AT 94120709 T AT94120709 T AT 94120709T AT E190836 T1 ATE190836 T1 AT E190836T1
Authority
AT
Austria
Prior art keywords
inner layer
drug formulation
water
active ingredients
controlled release
Prior art date
Application number
AT94120709T
Other languages
English (en)
Inventor
Keiji Fujioka
Takeshi Hirasawa
Masako Kajihara
Akihiro Sano
Shuichi Sugawara
Yosuke Urabe
Original Assignee
Dow Corning Asia Ltd
Sumitomo Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dow Corning Asia Ltd, Sumitomo Pharma filed Critical Dow Corning Asia Ltd
Application granted granted Critical
Publication of ATE190836T1 publication Critical patent/ATE190836T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0092—Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules or nanotubes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nanotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
AT94120709T 1993-12-27 1994-12-27 Arzneimittelzusammensetzung mit kontrollierter wirkstoffabgabe ATE190836T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP33146793A JP3720386B2 (ja) 1993-12-27 1993-12-27 薬物放出制御製剤

Publications (1)

Publication Number Publication Date
ATE190836T1 true ATE190836T1 (de) 2000-04-15

Family

ID=18243976

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94120709T ATE190836T1 (de) 1993-12-27 1994-12-27 Arzneimittelzusammensetzung mit kontrollierter wirkstoffabgabe

Country Status (15)

Country Link
US (1) US5851547A (de)
EP (1) EP0659406B1 (de)
JP (1) JP3720386B2 (de)
KR (1) KR100349960B1 (de)
CN (1) CN1107497C (de)
AT (1) ATE190836T1 (de)
AU (1) AU686713B2 (de)
CA (1) CA2139058C (de)
DE (1) DE69423582T2 (de)
DK (1) DK0659406T3 (de)
ES (1) ES2146633T3 (de)
GR (1) GR3033248T3 (de)
NZ (1) NZ277548A (de)
PT (1) PT659406E (de)
WO (1) WO1995017881A1 (de)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6056734A (en) * 1997-02-07 2000-05-02 Sarcos Lc Method for automatic dosing of drugs
TW586934B (en) * 1997-05-19 2004-05-11 Sumitomo Pharma Immunopotentiating composition
EP1001743B1 (de) 1997-06-04 2006-02-01 Debio Recherche Pharmaceutique S.A. Implantate zur gesteuerten freisetzung von pharmazeutischen wirkstoffen und verfahren zur herstellung
TW586944B (en) * 1998-05-29 2004-05-11 Sumitomo Pharma Controlled release agent having a multi-layer structure
US20020087184A1 (en) * 1998-06-18 2002-07-04 Eder Joseph C. Water-soluble coating for bioactive devices
CA2342587C (en) * 1998-09-10 2008-11-18 Sumitomo Pharmaceuticals Co., Ltd. Long term drug-sustained release preparation
US6217895B1 (en) 1999-03-22 2001-04-17 Control Delivery Systems Method for treating and/or preventing retinal diseases with sustained release corticosteroids
AU3957400A (en) 1999-04-16 2000-11-02 Novo Nordisk A/S Dry, mouldable drug formulation
JP2003507141A (ja) * 1999-08-25 2003-02-25 ジョージタウン ユニバーシティ 中空シード好ましくは金属製を含む治療用送達システム及びその用途
TW524696B (en) * 1999-11-10 2003-03-21 Sumitomo Pharma Sustained-release drug formulations
US6375972B1 (en) 2000-04-26 2002-04-23 Control Delivery Systems, Inc. Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
JP2002003406A (ja) * 2000-06-21 2002-01-09 Sankyo Co Ltd 脳血管攣縮予防製剤
EP1313425B1 (de) * 2000-07-14 2007-03-07 Novo Nordisk A/S Verfahren zum formen einer pharmazeutischen zusammensetzung in einem verpackungsmaterial
WO2003000156A1 (en) 2001-06-22 2003-01-03 Southern Biosystems, Inc. Zero-order prolonged release coaxial implants
AUPR602501A0 (en) * 2001-06-29 2001-07-26 Smart Drug Systems Inc Sustained release pharmaceutical composition
AUPR602401A0 (en) * 2001-06-29 2001-07-26 Smart Drug Systems Inc Sustained release delivery system
AUPR610501A0 (en) * 2001-07-04 2001-07-26 Smart Drug Systems Inc Treatment of parasitic disease
AUPR951501A0 (en) * 2001-12-14 2002-01-24 Smart Drug Systems Inc Modified sustained release pharmaceutical system
US8454997B2 (en) 2001-12-18 2013-06-04 Novo Nordisk A/S Solid dose micro implant
WO2003061634A1 (en) * 2002-01-24 2003-07-31 Smart Drug Systems Inc Sustained release pharmaceutical composition
JP4026745B2 (ja) * 2002-03-26 2007-12-26 財団法人大阪産業振興機構 医療用システムおよびその製造方法
US8871241B2 (en) 2002-05-07 2014-10-28 Psivida Us, Inc. Injectable sustained release delivery devices
AU2003240493B2 (en) 2002-05-31 2008-06-12 L. Molteni & C. Dei Fratelli Alitti Societa' Di Esercizio S.P.A. Implantable polymeric device for sustained release of buprenorphine
DE602004031512D1 (de) 2003-03-31 2011-04-07 Titan Pharmaceuticals Inc Polymeres implantat zur verzögerten freisetzung von dopamin antagonisten
TWI336627B (en) * 2003-05-23 2011-02-01 Organon Nv Drug delivery system,and use and manufacturing method thereof
ZA200509063B (en) * 2003-05-30 2007-03-28 Titan Pharmaceuticals Inc Impiantable polymeric device for sustained release of nalmefene
CA2530120A1 (en) * 2003-06-26 2005-01-06 Mediolanum Pharmaceuticals Ltd. Subcutaneous implants having limited initial release of the active principle and subsequent linearly varying extended release thereof
EP1781264B1 (de) 2004-08-04 2013-07-24 Evonik Corporation Verfahren zur herstellung von abgabevorrichtungen und damit erhaltene vorrichtungen
EP1968383B1 (de) 2005-12-12 2011-05-11 Women and Infants Hospital of Rhode Island Derivate von vitamin d und ihre verwendung in der therapie
WO2008060360A2 (en) * 2006-09-28 2008-05-22 Surmodics, Inc. Implantable medical device with apertures for delivery of bioactive agents
WO2008070557A2 (en) * 2006-12-01 2008-06-12 Women & Infants Hospital Organometallic complexes as therapeutic agents
US20080153906A1 (en) * 2006-12-13 2008-06-26 Celly Chander S Water-Soluble Phenicol Prodrugs in a Lipophilic Vehicle System
CA2676527C (en) 2007-01-24 2015-08-11 Women & Infants Hospital N-amino tetrahydrothiazine derivatives, method of manufacture and use
US8741329B2 (en) 2007-09-21 2014-06-03 Merck Sharp & Dohme B.V. Drug delivery system
WO2009085952A1 (en) 2007-12-20 2009-07-09 Brookwood Pharmaceuticals, Inc. Process for preparing microparticles having a low residual solvent volume
JP2012517434A (ja) 2009-02-06 2012-08-02 ザ ジェネラル ホスピタル コーポレイション 血管病変を治療する方法
EP2246063A1 (de) 2009-04-29 2010-11-03 Ipsen Pharma S.A.S. GnRH Analoge enthaltende Retardformulierungen
AU2010256558B2 (en) 2009-06-03 2013-10-03 Forsight Labs, Llc Anterior segment drug delivery
WO2012018068A1 (ja) 2010-08-06 2012-02-09 大日本住友製薬株式会社 水溶性薬物放出制御製剤
CN103140226B (zh) 2010-08-06 2015-07-08 大日本住友制药株式会社 用于治疗脊髓损伤的制剂
KR102192603B1 (ko) 2011-09-14 2020-12-17 포사이트 비젼5, 인크. 안내 삽입물 장치 및 방법
RU2652063C2 (ru) 2012-10-26 2018-04-24 Форсайт Вижн5, Инк. Офтальмологическая система для замедленного высвобождения лекарственного средства в глазу
HUE051406T2 (hu) 2012-11-14 2021-03-01 Grace W R & Co Biológiailag aktív anyagot és rendezetlen szervetlen oxidot tartalmazó kompozíciók
EP3079659B1 (de) 2013-12-11 2020-10-28 Merck Sharp & Dohme B.V. Arzneimittelliefersystem zur verabreichung von virenbekämpfungsmitteln
US10413504B2 (en) 2013-12-11 2019-09-17 Merck Sharp & Dohme Corp. Intravaginal ring drug delivery system
JP6359390B2 (ja) * 2014-09-05 2018-07-18 テルモ株式会社 インプラントデバイスおよびインプラントデバイス植え込み具
US20160296532A1 (en) 2015-04-13 2016-10-13 Forsight Vision5, Inc. Ocular Insert Composition of a Semi-Crystalline or Crystalline Pharmaceutically Active Agent
US20210007973A1 (en) * 2016-10-05 2021-01-14 Titan Pharmaceuticals, Inc. Implantable devices for drug delivery with reduced burst release
US20210113664A1 (en) * 2018-06-25 2021-04-22 Titan Pharmaceuticals, Inc. Implants for release of lipophilic or amphiphilic pharmaceutical substances
KR102442807B1 (ko) * 2021-01-29 2022-09-15 주식회사 티온랩테라퓨틱스 초기 방출 제어된 데포 조성물 및 이의 제조방법

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3710795A (en) * 1970-09-29 1973-01-16 Alza Corp Drug-delivery device with stretched, rate-controlling membrane
US4351337A (en) * 1973-05-17 1982-09-28 Arthur D. Little, Inc. Biodegradable, implantable drug delivery device, and process for preparing and using the same
FR2240817B1 (de) * 1973-08-16 1981-04-17 Roland Offsetmaschf
JPS5513381Y2 (de) * 1974-02-21 1980-03-26
US3926188A (en) * 1974-11-14 1975-12-16 Alza Corp Laminated drug dispenser
JPS58781B2 (ja) * 1978-07-17 1983-01-07 風早 清志 畳表の自動裁断装置
US4191741A (en) * 1978-09-22 1980-03-04 Eli Lilly And Company Removable drug implant
DE3022800A1 (de) * 1980-06-19 1982-01-07 Bayer Ag, 5090 Leverkusen Verfahren zur temperaturregelung exothermer reaktionen durch ueberhitzung von wasserdampf
JPS62174031A (ja) * 1985-10-11 1987-07-30 Sumitomo Pharmaceut Co Ltd 高分子量薬物含有徐放性製剤
NZ217844A (en) * 1985-10-11 1989-10-27 Sumitomo Pharma A sustained release pharmaceutical composition containing silicone elastomer and an albumin
IT1188212B (it) * 1985-12-20 1988-01-07 Paolo Colombo Sistema per il rilascio a velocita' controllata di sostanze attive
DE3769707D1 (de) * 1986-06-17 1991-06-06 Recordati Chem Pharm Therapeutisches system mit geregelter wirkstoffabgabe.
US5322691A (en) * 1986-10-02 1994-06-21 Sohrab Darougar Ocular insert with anchoring protrusions
US4891223A (en) * 1987-09-03 1990-01-02 Air Products And Chemicals, Inc. Controlled release delivery coating formulation for bioactive substances
EP0406315B1 (de) * 1988-03-24 1992-11-11 Bukh Meditec A/S Geregelte verabreichungszusammensetzung
DK606288D0 (da) * 1988-03-24 1988-10-31 Bukh Meditec Praeparat
JPH02142738A (ja) * 1988-11-24 1990-05-31 Nippon Zeon Co Ltd 徐放性医薬製剤およびその製法
JP3118009B2 (ja) * 1991-04-16 2000-12-18 住友製薬株式会社 多層構造を有するコラーゲンおよび／またはゼラチン製剤の製造方法
JPH06321803A (ja) * 1993-05-17 1994-11-22 Kirin Brewery Co Ltd 水溶性ペプチドホルモンの徐放性製剤

Also Published As

Publication number Publication date
AU686713B2 (en) 1998-02-12
GR3033248T3 (en) 2000-09-29
DE69423582D1 (de) 2000-04-27
DE69423582T2 (de) 2000-09-07
CN1142763A (zh) 1997-02-12
CN1107497C (zh) 2003-05-07
US5851547A (en) 1998-12-22
ES2146633T3 (es) 2000-08-16
JPH07187994A (ja) 1995-07-25
KR100349960B1 (ko) 2003-03-06
EP0659406B1 (de) 2000-03-22
JP3720386B2 (ja) 2005-11-24
CA2139058C (en) 2004-11-16
NZ277548A (en) 1997-05-26
AU1280995A (en) 1995-07-17
CA2139058A1 (en) 1995-06-28
EP0659406A2 (de) 1995-06-28
WO1995017881A1 (en) 1995-07-06
EP0659406A3 (de) 1995-11-15
DK0659406T3 (da) 2000-07-03
PT659406E (pt) 2000-06-30

Similar Documents

Publication Publication Date Title
ATE190836T1 (de) Arzneimittelzusammensetzung mit kontrollierter wirkstoffabgabe
GB2341550A (en) Gastroretentive controlled release microspheres for improved drug delivery
BR9607752A (pt) Formulação farmacêutica de microcápsula de liberação controlada, processo para sua preparação, e, processo de uso das microcápsulas
ATE195252T1 (de) Wirkstoffabgabevorrichtung mit gesteuerter freigabe
GEP20022833B (en) New Controlled Release Bead, Method of Producing the Same and Multiple Unit Formulation Comprising It
MX9700850A (es) Formulaciones y metodos para proporcionar anestesia local prolongada.
UA29563C2 (uk) Мікрокапсула для тривалого вивільнення фізіологічно активного пептиду
DK0841903T3 (da) Orale farmaceutiske præparater indeholdende antimikrobielt virksomme aktivstoffer og sustained release pantoprazol
ATE290836T1 (de) Intravaginal-ringe mit einsetzbarem medikamentenenthaltenden kern
DK0610178T3 (da) Terapeutisk præparat og fremgangsmåde til dets fremstilling
DK1112739T3 (da) Langtidsafgivende depot-præparat
ES491307A0 (es) Un procedimiento para la preparacion de una composicion de liberacion controlada de un compuesto biologicamente activo para su administracion a un animal
GR3006966T3 (en) Pharmaceutical composition comprising a medicament and a water-swellable polymer
DK0416722T3 (da) Farmaceutiske præparater med differentieret medikamentfrigivelseshastighed
IT1317871B1 (it) Sistemi terapeutici per forme farmaceutiche orali di principi attiviaventi sfavorevoli caratteristiche organolettiche.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner
EEIH Change in the person of patent owner